Troy Rafferty Secures $700 Million Settlement in Opioid Litigation

In one of the most significant legal battles of recent years, Troy Rafferty was a key player in securing a landmark $700 million settlement in opioid litigation. This massive settlement was part of a broader, nationwide effort to hold pharmaceutical companies accountable for their role in fueling the opioid epidemic, which has ravaged communities across the United States for over a decade.

Rafferty’s work on this case spanned years of intense legal battles. He represented numerous state and local governments that had been forced to bear the financial burden of dealing with the crisis. Rafferty and his team worked to prove that drug manufacturers and distributors had engaged in deceptive practices, aggressively marketing opioid medications while downplaying their addictive properties, all in the pursuit of profit.

Through meticulous evidence gathering, Rafferty helped expose the companies’ internal documents that revealed how they misled healthcare professionals and patients about the risks of opioids, all while addiction and overdose deaths skyrocketed. The settlement provided $700 million to state and local governments for addiction treatment programs, public health initiatives, and other services to help combat the crisis.This victory represents a turning point in the ongoing litigation surrounding the opioid crisis, and it stands as a powerful example of Rafferty’s commitment to securing justice for communities devastated by corporate greed. For more information on this case, learn more about the opioid litigation here